Nano-silver - feasibility and challenges for human health risk assessment based on open literature.
about
Applications of nanotechnology in dermatologyPhysicochemical characteristics of nanomaterials that affect pulmonary inflammationRisk assessment principle for engineered nanotechnology in food and drugThe effects of nano-silver and garlic administration during pregnancy on neuron apoptosis in rat offspring hippocampusSilver Nanoparticle-Directed Mast Cell Degranulation Is Mediated through Calcium and PI3K Signaling Independent of the High Affinity IgE ReceptorParticle size dependent deposition and pulmonary inflammation after short-term inhalation of silver nanoparticlesShape matters: effects of silver nanospheres and wires on human alveolar epithelial cellsNeeds and challenges for assessing the environmental impacts of engineered nanomaterials (ENMs).In vitro and in vivo interactions of selected nanoparticles with rodent serum proteins and their consequences in biokineticsInfluence of physicochemical properties of silver nanoparticles on mast cell activation and degranulation.Effect of poly-α, γ, L-glutamic acid as a capping agent on morphology and oxidative stress-dependent toxicity of silver nanoparticles.Exploring the effect of silver nanoparticle size and medium composition on uptake into pulmonary epithelial 16HBE14o-cellsA physiologically based pharmacokinetic model for ionic silver and silver nanoparticles.Uptake of silver nanoparticles by monocytic THP-1 cells depends on particle size and presence of serum proteins.A Tractable Method for Measuring Nanomaterial Risk Using Bayesian Networks.Review of carbon nanotubes toxicity and exposure--appraisal of human health risk assessment based on open literature.Engineered nanomaterial risk. Lessons learnt from completed nanotoxicology studies: potential solutions to current and future challenges.Nanosilver: application and novel aspects of toxicology.Challenges in assessing release, exposure and fate of silver nanoparticles within the UK environment.Nanosilver-based antibacterial drugs and devices: mechanisms, methodological drawbacks, and guidelines.How physico-chemical characteristics of nanoparticles cause their toxicity: complex and unresolved interrelations.Multispecies toxicity test for silver nanoparticles to derive hazardous concentration based on species sensitivity distribution for the protection of aquatic ecosystems.Negative pressure and nanocrystalline silver dressings for nonhealing ulcer: A randomized pilot study.A new, simple, green, and one-pot four-component synthesis of bare and poly(α,γ, L-glutamic acid)-capped silver nanoparticlesZeta potential and solubility to toxic ions as mechanisms of lung inflammation caused by metal/metal oxide nanoparticles.Physicochemical characterization and in vitro hemolysis evaluation of silver nanoparticles.State of the art in human risk assessment of silver compounds in consumer products: a conference report on silver and nanosilver held at the BfR in 2012.Impact of Predator Cues on Responses to Silver Nanoparticles in Daphnia carinata.Aquatic toxicity of nanosilver colloids to different trophic organisms: contributions of particles and free silver ion.Characterizing risk assessments for the development of occupational exposure limits for engineered nanomaterials.Engineered Nanomaterials: Knowledge Gaps in Fate, Exposure, Toxicity, and Future DirectionsWearable silver nanowire dry electrodes for electrophysiological sensingWide Reflective Equilibrium as a Normative Model for Responsible Governance
P2860
Q24170384-DCDC8A73-C774-4896-8C0E-C48628CF9072Q26859438-5F53E7B3-BB0C-41E6-B20E-FAC6791C9A41Q28391288-54A9E790-B753-4361-87E6-63E661125E17Q28392692-9795C968-0455-4133-88EC-B1B711496355Q28395528-FF7DB1AC-3350-40A7-8774-958051B4E61BQ29248667-841D592C-7218-47FB-A4CB-AE7E611FE18EQ29248685-9ECFBB85-9AAA-4C24-BA1C-A1699B72D6FCQ33692205-93757252-ECDC-4408-82F4-2B117304E938Q34463566-A3165029-26EE-41A7-8C5D-30621B40EA90Q34964232-DAEE15DA-8F45-4A21-BB74-318095F2FAF0Q35574694-615A6E35-A4CF-4A35-9F16-4E2B3263D161Q37060011-A4EFAB8D-FEB9-441E-9246-37451C19B4DEQ37167472-46827191-02FF-4243-B0F2-05C82511445BQ37277466-C64CC7A6-8554-4B5C-86CE-4852DF195F84Q37415890-43711A60-B466-4BBB-BFB8-28AC968CDE08Q37791170-C18548AF-69A2-4480-B6B1-17163A68292EQ38057778-2C3B86F7-06FD-4065-8686-4310191E35B7Q38076310-8FB2ACCB-0582-4DE8-A73F-7E4454B630B8Q38140620-8D3B0160-B89B-4FC8-91A6-E3568A19C4D1Q38167600-ABBE8613-1189-4728-BAB8-B20D6C0E34C1Q38193109-246DEF68-F177-4144-BBF7-4C72120B5EBEQ40244428-B9BA449B-A5FC-48BF-B46A-CC4370EAE3A6Q40615118-7DB7CF1F-4CFA-47B5-B8EA-2ACB4CF18186Q42648217-C3795560-0600-456B-A3AD-1D04D00EE450Q42722450-97FCA1E1-165D-4511-A873-74135952ED25Q42732635-2705E985-11B1-4ADD-B78C-BFB0CE5BEE6DQ42866292-727D73D8-AF56-4E90-8C8A-CC483A016B27Q50583845-2CC6E81C-7ED0-4445-ABAE-6DD3298E164CQ51554423-245DD9C6-DFCA-4C8A-983C-3D7134B1282EQ52638280-8D2FE1ED-C631-4F7C-8C7D-0361407CDA4DQ57256118-E7867A62-675D-4005-BCFE-15ED7F64E3F3Q57439863-D0F311D3-C9A0-4867-95D8-F67E577129ADQ59154183-08563862-B9D9-46D8-B113-D6DF722C9A75
P2860
Nano-silver - feasibility and challenges for human health risk assessment based on open literature.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Nano-silver - feasibility and ...... ment based on open literature.
@en
Nano-silver - feasibility and ...... ment based on open literature.
@nl
type
label
Nano-silver - feasibility and ...... ment based on open literature.
@en
Nano-silver - feasibility and ...... ment based on open literature.
@nl
prefLabel
Nano-silver - feasibility and ...... ment based on open literature.
@en
Nano-silver - feasibility and ...... ment based on open literature.
@nl
P2093
P2860
P1433
P1476
Nano-silver - feasibility and ...... ment based on open literature.
@en
P2093
Frans M Christensen
Karin Aschberger
Robert J Aitken
Sheona Peters
Steve Hankin
P2860
P304
P356
10.3109/17435391003690549
P577
2010-09-01T00:00:00Z